AKT1 and diffuse large B-cell lymphoma: Moreover, DLBCL patients with co-expression of PD-L1 and p-AKT had the worst 3 years OS (P=0.005, Figure 3C) and 5 years OS (P=0.008, Figure 3F) compared to patients with single positive or both negative expression of PD-L1 and p-AKT.